The development of an ‘artificial pancreas’ could revolutionise the daily lives of people living with type 1 diabetes. Now the technology could be made available to more than 100,000 people in the UK on the NHS
More than 100,000 people with type 1 diabetes in England will be offered an “artificial pancreas”, in a revolutionary new treatment for managing the condition.
The so-called closed-loop system uses an algorithm to determine the amount of insulin that should be administered to the user and reads blood sugar levels to keep them steady. For thousands of people in the UK, living with diabetes means regular finger-pricking, insulin injections and blood monitoring. But those time-consuming and sometimes stressful processes would become automated by the new treatment, which is being called a “holy grail” for those with diabetes.